0001447362-21-000148.txt : 20210617 0001447362-21-000148.hdr.sgml : 20210617 20210617173625 ACCESSION NUMBER: 0001447362-21-000148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210615 FILED AS OF DATE: 20210617 DATE AS OF CHANGE: 20210617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stokes Frank CENTRAL INDEX KEY: 0001782815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 211026038 MAIL ADDRESS: STREET 1: C/O CASTLE BIOSCIENCES STREET 2: 820 S. FRIENDSWOOD DRIVE, SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770701774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 4 1 wf-form4_162396576996441.xml FORM 4 X0306 4 2021-06-15 0 0001447362 CASTLE BIOSCIENCES INC CSTL 0001782815 Stokes Frank C/O CASTLE BIOSCIENCES, INC. 505 S. FRIENDSWOOD DRIVE, SUITE 401 FRIENDSWOOD TX 77546 0 1 0 0 Chief Financial Officer Common Stock 2021-06-15 4 M 0 11600 2.39 A 17520 D Common Stock 2021-06-15 4 S 0 11600 73.02 D 5920 D Common Stock 2021-06-16 4 M 0 2127 2.39 A 8047 D Common Stock 2021-06-16 4 S 0 2127 73.07 D 5920 D Common Stock 2021-06-17 4 M 0 1273 2.39 A 7193 D Common Stock 2021-06-17 4 S 0 1273 73 D 5920 D Stock option (right to buy) 2.39 2021-06-15 4 M 0 11600 0 D 2028-05-09 Common Stock 11600.0 28537 D Stock option (right to buy) 2.39 2021-06-16 4 M 0 2127 0 D 2028-05-09 Common Stock 2127.0 26410 D Stock option (right to buy) 2.39 2021-06-17 4 M 0 1273 0 D 2028-05-09 Common Stock 1273.0 25137 D These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 14, 2021. Includes 2,034 shares acquired on February 26, 2021 under the Issuer's employee stock purchase plan. This transaction was executed in multiple trades at prices ranging from $73.00 to $73.13, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $73.00 to $73.33, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option is exercisable immediately, in whole or in part, conditioned upon the Reporting Person entering into a restricted stock purchase agreement with respect to any unvested shares. 25% of the 133,137 shares originally subject to the option vested on December 4, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Greg Acosta, Attorney-in-fact 2021-06-17